SCHEMBL8302598

SCHEMBL8302598

CCCCOc1ccc(NC(=O)CNCc2ccccc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.70
KMT2A Q03164 4/20 0.63
MEN1 O00255 3/20 0.63
HPGD P15428 2/20 0.56
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
GAA P10253 3/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
FAAH O00519 6/20 0.55
LTA4H P09960 1/20 0.54
LMNA P02545 2/20 0.53
KDM4E B2RXH2 2/20 0.53
ALDH1A1 P00352 2/20 0.53
MAPT P10636 2/20 0.53
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6721335 0.85 RECQL (0.75) RECQLKMT2AMEN1NPC1RAB9A
SCHEMBL15203359 0.82 KMT2A (0.62) KMT2AMEN1NPC1RAB9AGAA
SCHEMBL22069657 0.82 RECQL (1.00) RECQLKMT2AMEN1HPGDSMN1; SMN2
SCHEMBL27852723 0.80 RECQL (0.74) RECQLKMT2AMEN1HPGDGAA
SCHEMBL6725374 0.80 NR1H4 (0.61) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL5105487 0.79 LMNA (0.57) SMN1; SMN2FAAHLMNAKDM4EALDH1A1
SCHEMBL8495474 0.78 LTA4H (0.55) RECQLKMT2AMEN1NPC1RAB9A
SCHEMBL31022551 0.77 GAA (0.67) SMN1; SMN2GAAL3MBTL1FAAHLMNA
SCHEMBL401828 0.77 RECQL (0.66) RECQLKMT2AMEN1HPGDNPC1
SCHEMBL5864374 0.76 RECQL (0.69) RECQLKMT2AMEN1HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004089915-A1 PIPERAZINE DERIVATIVE RENIN INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2004-10-21 WO disclosed